BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

BIM

115.5

+1.49%↑

SRT3

228.3

-0.7%↓

GXI

55.3

+2.88%↑

ICAD

21.08

-0.57%↓

Search

Fresenius SE & Co KGaA

Închisă

SectorSănătate

39.86 -0.2

Rezumat

Modificarea prețului

24h

Curent

Minim

39.7

Maxim

40.25

Indicatori cheie

By Trading Economics

Venit

-48M

271M

Vânzări

264M

5.6B

P/E

Medie Sector

24.381

57.333

Marjă de profit

4.813

Angajați

176,486

EBITDA

-33M

724M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+17.39% upside

Dividende

By Dow Jones

Următoarele câștiguri

7 mai 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

1.1B

22B

Deschiderea anterioară

40.06

Închiderea anterioară

39.86

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

Fresenius SE & Co KGaA Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

26 feb. 2025, 13:37 UTC

Market Talk

European Stocks on Track for Record Close as Earnings Lift Mood -- Market Talk

5 iun. 2024, 12:18 UTC

Market Talk

Fresenius Helios Guidance Lift Should Drive Consensus Upgrades -- Market Talk

Comparație

Modificare preț

Fresenius SE & Co KGaA Așteptări

Obiectiv de preț

By TipRanks

17.39% sus

Prognoză pe 12 luni

Medie 46.78 EUR  17.39%

Maxim 56.9 EUR

Minim 42 EUR

În baza a 13 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruFresenius SE & Co KGaA - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

13 ratings

11

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

39.5 / 39.92Suport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Weak Bearish Evidence

Termen lung

Bullish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Fresenius SE & Co KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.